Jennifer Jones-McMeans

Jennifer Jones-McMeans, Ph.D. Divisional Vice President of Global Clinical Affairs in Abbott’s vascular business
Areas of Expertise: Vascular health, medical devices, bioresorbable technology, health equity, clinical trial design strategy, and hypertension research

As the Divisional Vice President of Global Clinical Affairs in Abbott’s vascular business, Jennifer Jones-McMeans is invested in driving innovation and leveraging technology to bring new medical devices to market globally.

Since joining Abbott as a clinical research scientist more than 15 years ago, Jennifer has worked on gaining approval of numerous medical devices in the United States and globally. Jennifer has led many clinical trials, including those for resorbable technologies designed to treat cardiovascular diseases such as peripheral artery disease.

In 2021, Jennifer launched a new initiative designed to help create a more inclusive clinical trial ecosystem and clinical research infrastructure and currently co-leads Abbott’s Diversity in Research Office.

Jennifer has spoken at several renowned industry conferences on the topic of diversity in clinical trials, including HIMSS 2022, Diversity in Clinical Trials Summit, American Diabetes Association 2023 Sessions, CTTI-FDA Public Workshop to Enhance Clinical Study Diversity, and more. In addition, Jennifer has received the Silicon Valley Women of Influence Award for her work eliminating barriers to clinical trials and is nominated for several other accolades.

Jennifer received her bachelor of arts from the University of San Francisco and earned her master of science from California State University East Bay. She also received her Ph.D. in Philosophy from the University of Maryland.

Media Coverage:
• Hospital and Healthcare Management: Unlocking the Power of Diversity in Clinical Trials: A Formula for a Healthier Healthcare System.
• Healthcare Digital: Interview with Jennifer Jones-McMeans.
• Express Healthcare Management: Breaking Down Barriers: Abbott’s Commitment to Diversity in Clinical Trials.
• Chief Healthcare Executive: Addressing the lack of diversity in clinical trials: Four lessons for healthcare leaders | Viewpoint.
• Healthcare Digital: Top 10 healthcare businesses in the USA.
• US Black Engineer: Podcast of the day: Friday, August 11, 2023.